- Home
- REPL vs IAUX Comparison
REPL vs IAUX Comparison
Compare REPL & IAUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- IAUX
- Stock Information
- Founded
- REPL 2015
- IAUX 2020
- Country
- REPL United States
- IAUX United States
- Employees
- REPL N/A
- IAUX N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- IAUX
- Sector
- REPL Health Care
- IAUX
- Exchange
- REPL Nasdaq
- IAUX Nasdaq
- Market Cap
- REPL 547.0M
- IAUX 507.4M
- IPO Year
- REPL 2018
- IAUX N/A
- Fundamental
- Price
- REPL $5.71
- IAUX $0.91
- Analyst Decision
- REPL Hold
- IAUX Buy
- Analyst Count
- REPL 9
- IAUX 1
- Target Price
- REPL $7.00
- IAUX $1.50
- AVG Volume (30 Days)
- REPL 2.1M
- IAUX 4.9M
- Earning Date
- REPL 11-11-2025
- IAUX 11-11-2025
- Dividend Yield
- REPL N/A
- IAUX N/A
- EPS Growth
- REPL N/A
- IAUX N/A
- EPS
- REPL N/A
- IAUX N/A
- Revenue
- REPL N/A
- IAUX $76,622,000.00
- Revenue This Year
- REPL N/A
- IAUX $79.79
- Revenue Next Year
- REPL $408.25
- IAUX $92.04
- P/E Ratio
- REPL N/A
- IAUX N/A
- Revenue Growth
- REPL N/A
- IAUX 40.21
- 52 Week Low
- REPL $2.68
- IAUX $0.34
- 52 Week High
- REPL $17.00
- IAUX $1.26
- Technical
- Relative Strength Index (RSI)
- REPL 46.92
- IAUX 66.90
- Support Level
- REPL $5.60
- IAUX $0.86
- Resistance Level
- REPL $6.15
- IAUX $0.95
- Average True Range (ATR)
- REPL 0.33
- IAUX 0.04
- MACD
- REPL 0.06
- IAUX 0.00
- Stochastic Oscillator
- REPL 32.48
- IAUX 79.32
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.
About IAUX i-80 Gold Corp.
i-80 Gold Corp is a well-financed gold and silver producer engaged in the exploration, development, and production of gold, silver, and poly-metallic deposits. The Company's principal assets include the Ruby Hill Mine, Lone Tree Mine, Granite Creek Mine, and McCoy-Cove Project.